| Terminated | A Study of OMP-336B11 in Subjects With Locally Advanced or Metastatic Tumors Locally Advanced Malignant Neoplasm, Metastatic Cancer | Phase 1 | 2017-09-12 |
| Terminated | A Study of OMP-313M32 in Subjects With Locally Advanced or Metastatic Solid Tumors Locally Advanced Cancer, Metastatic Cancer | Phase 1 | 2017-05-02 |
| Completed | A Study of Brontictuzumab With Chemotherapy for Subjects With Previously Treated Metastatic Colorectal Cancer Metastatic Colorectal Cancer | Phase 1 | 2017-01-01 |
| Completed | A Phase 1b Study of OMP-305B83 Plus Paclitaxel in Subjects With Ovarian, Peritoneal or Fallopian Tube Cancer Cancer Ovaries, Cancer Peritoneal, Cancer, Fallopian Tube | Phase 1 | 2016-12-01 |
| Terminated | A Study of OMP-305B83 in Subjects With Metastatic Colorectal Cancer Metastatic Colorectal Cancer | Phase 1 | 2016-12-01 |
| Completed | A Phase 1b Study of Demcizumab Plus Pembrolizumab in Locally Advanced or Metastatic Solid Tumors Locally Advanced or Metastatic Solid Tumors | Phase 1 | 2016-01-01 |
| Completed | A Phase 1a/b Dose Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of OMP-131R10 Advanced Relapsed Tumors, Refractory Solid Tumors | Phase 1 | 2015-07-16 |
| Completed | Study of Gemcitabine, Abraxane® Plus Placebo Versus Gemcitabine, Abraxane® Plus 1 or 2 Truncated Courses of De Pancreatic Cancer | Phase 2 | 2015-04-20 |
| Completed | A Study of Carboplatin, Pemetrexed Plus Placebo vs Carboplatin, Pemetrexed Plus 1 or 2 Truncated Courses of De Nonsquamous Nonsmall Cell Neoplasm of Lung | Phase 2 | 2015-02-01 |
| Completed | A Phase 1 Study of OMP-305B83 in Subjects With Solid Tumors Advanced Solid Tumor Malignancies | Phase 1 | 2014-12-22 |
| Completed | Dose Escalation Study of OMP-54F28 in Combination With Sorafenib in Patients With Hepatocellular Cancer Hepatocellular Cancer, Liver Cancer | Phase 1 | 2014-01-01 |
| Completed | Dose Escalation Study of OMP-54F28 in Combination With Paclitaxel and Carboplatin in Patients With Recurrent P Ovarian Cancer | Phase 1 | 2014-01-01 |
| Completed | Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previou Pancreatic Cancer, Stage IV Pancreatic Cancer | Phase 1 | 2013-11-01 |
| Completed | A Study of Vantictumab (OMP-18R5) in Combination With Nab-Paclitaxel and Gemcitabine in Previously Untreated S Pancreatic Cancer, Stage IV Pancreatic Cancer | Phase 1 | 2013-09-01 |
| Completed | A Study of Vantictumab (OMP-18R5) in Combination With Docetaxel in Patients With Previously Treated NSCLC Solid Tumors | Phase 1 | 2013-09-01 |
| Completed | A Study of Vantictumab (OMP-18R5) in Combination With Paclitaxel in Locally Recurrent or Metastatic Breast Can Metastatic Breast Cancer | Phase 1 | 2013-09-01 |
| Terminated | A Study of Demcizumab Plus Paclitaxel in Subjects With Platinum Resistant Ovarian Primary Peritoneal Carcinoma | Phase 1 | 2013-08-05 |
| Completed | A Dose Escalation Study of OMP-52M51 in Subjects With Solid Tumors Relapsed or Refractory Solid Tumors | Phase 1 | 2013-02-01 |
| Completed | A Dose Escalation Study of OMP-52M51 in Subjects With Lymphoid Malignancies Relapsed or Refractory Lymphoid Malignancies | Phase 1 | 2012-10-01 |
| Completed | A Phase 1b/2 Study of OMP-59R5 (Tarextumab) in Combination With Nab-Paclitaxel and Gemcitabine in Subjects Wit Stage IV Pancreatic Cancer | Phase 1 / Phase 2 | 2012-10-01 |
| Completed | A Dose Escalation Study of OMP-54F28 in Subjects With Solid Tumors Solid Tumors | Phase 1 | 2012-06-01 |
| Terminated | A Phase 1b/2 Study of OMP-59R5 (Tarextumab) in Combination With Etoposide and Platinum Therapy Stage IV Small Cell Lung Cancer | Phase 1 / Phase 2 | 2012-01-07 |
| Completed | A Dose Escalation Study of OMP-18R5 in Subjects With Solid Tumors Solid Tumors | Phase 1 | 2011-05-01 |
| Completed | A Dose Escalation Study of OMP-59R5 in Subjects With Solid Tumors Solid Tumors | Phase 1 | 2010-12-01 |
| Completed | A Study of FOLFIRI Plus OMP-21M18 as 1st or 2nd-line Treatment in Subjects With Metastatic Colorectal Cancer Colorectal Cancer | Phase 1 | 2010-09-01 |
| Completed | A Study of Carboplatin and Pemetrexed Plus Demcizumab (OMP-21M18) in Subjects With Non-Squamous Non-Small Cell Non Small Cell Lung Cancer | Phase 1 | 2010-09-01 |
| Completed | A Study of Gemcitabine and Demcizumab (OMP-21M18) With or Without Abraxane® as 1st-line Treatment in Subjects Pancreatic Cancer | Phase 1 | 2010-08-01 |
| Completed | A Phase 1 Dose Escalation Study of OMP-21M18 in Subjects With Solid Tumors Solid Tumors | Phase 1 | 2008-08-01 |